|
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CCDC64B |
Gene summary for CCDC64B |
| Gene information | Species | Human | Gene symbol | CCDC64B | Gene ID | 146439 |
| Gene name | BICD family like cargo adaptor 2 | |
| Gene Alias | BICDR-2 | |
| Cytomap | 16p13.3 | |
| Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | A1A5D9 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 146439 | CCDC64B | P36T-E | Human | Esophagus | ESCC | 2.11e-03 | 2.08e-01 | 0.1187 |
| 146439 | CCDC64B | P37T-E | Human | Esophagus | ESCC | 1.42e-10 | 2.94e-01 | 0.1371 |
| 146439 | CCDC64B | P38T-E | Human | Esophagus | ESCC | 3.67e-05 | 2.49e-01 | 0.127 |
| 146439 | CCDC64B | P39T-E | Human | Esophagus | ESCC | 7.28e-26 | 6.14e-01 | 0.0894 |
| 146439 | CCDC64B | P40T-E | Human | Esophagus | ESCC | 1.47e-07 | 2.71e-01 | 0.109 |
| 146439 | CCDC64B | P42T-E | Human | Esophagus | ESCC | 8.55e-05 | 1.86e-01 | 0.1175 |
| 146439 | CCDC64B | P44T-E | Human | Esophagus | ESCC | 1.25e-08 | 3.12e-01 | 0.1096 |
| 146439 | CCDC64B | P47T-E | Human | Esophagus | ESCC | 9.35e-10 | 2.91e-01 | 0.1067 |
| 146439 | CCDC64B | P48T-E | Human | Esophagus | ESCC | 1.88e-11 | 2.38e-01 | 0.0959 |
| 146439 | CCDC64B | P52T-E | Human | Esophagus | ESCC | 1.78e-03 | 1.22e-01 | 0.1555 |
| 146439 | CCDC64B | P54T-E | Human | Esophagus | ESCC | 3.18e-24 | 5.82e-01 | 0.0975 |
| 146439 | CCDC64B | P56T-E | Human | Esophagus | ESCC | 6.66e-05 | 5.31e-01 | 0.1613 |
| 146439 | CCDC64B | P57T-E | Human | Esophagus | ESCC | 1.75e-25 | 4.90e-01 | 0.0926 |
| 146439 | CCDC64B | P61T-E | Human | Esophagus | ESCC | 2.46e-17 | 3.52e-01 | 0.099 |
| 146439 | CCDC64B | P62T-E | Human | Esophagus | ESCC | 3.28e-38 | 7.12e-01 | 0.1302 |
| 146439 | CCDC64B | P65T-E | Human | Esophagus | ESCC | 3.23e-15 | 3.61e-01 | 0.0978 |
| 146439 | CCDC64B | P74T-E | Human | Esophagus | ESCC | 1.08e-19 | 5.47e-01 | 0.1479 |
| 146439 | CCDC64B | P75T-E | Human | Esophagus | ESCC | 7.66e-49 | 1.08e+00 | 0.1125 |
| 146439 | CCDC64B | P76T-E | Human | Esophagus | ESCC | 1.53e-19 | 4.07e-01 | 0.1207 |
| 146439 | CCDC64B | P79T-E | Human | Esophagus | ESCC | 8.08e-19 | 4.28e-01 | 0.1154 |
| Page: 1 2 3 4 |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD | ![]() |
| Colorectum | SER | ![]() |
| Colorectum | MSS | ![]() |
| Colorectum | MSI-H | ![]() |
| Colorectum | FAP | ![]() |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| hsa048144 | Endometrium | AEH | Motor proteins | 42/1197 | 193/8465 | 2.41e-03 | 1.42e-02 | 1.04e-02 | 42 |
| hsa0481411 | Endometrium | AEH | Motor proteins | 42/1197 | 193/8465 | 2.41e-03 | 1.42e-02 | 1.04e-02 | 42 |
| hsa048142 | Endometrium | EEC | Motor proteins | 42/1237 | 193/8465 | 4.43e-03 | 2.39e-02 | 1.78e-02 | 42 |
| hsa048143 | Endometrium | EEC | Motor proteins | 42/1237 | 193/8465 | 4.43e-03 | 2.39e-02 | 1.78e-02 | 42 |
| Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |